College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, PR China.
Parasitology. 2012 Nov;139(13):1711-9. doi: 10.1017/S0031182012001163. Epub 2012 Aug 21.
Eimeria spp. are the causative agents of coccidiosis, a major disease affecting the poultry industry. So far, only a few antigen genes of E. acervulina have been reported. In this study, a clone, named as cSZ-JN2, was identified from a cDNA expression library prepared from E. acervulina sporozoite stage with the ability to stimulate the chicken immune response. The sequence analysis showed that the open reading fragment (ORF) of cSZ-JN2 was 153 bp in size and encoded a predicted protein of 50 amino acids of Mr 5·3 kDa. BLASTN search revealed that cSZ-JN2 had no significant homology with the known genes of E. acervulina or any other organism (GenBank). The recombinant cSZ-JN2 antigen expressed in E. coli was recognized strongly by serum from chickens experimentally infected with E. acervulina. Immunofluorescence analysis using antibody against recombinant cSZ-JN2 indicated that this protein was expressed in sporozoite and merozoite developmental stages. Animal challenge experiments demonstrated that the recombinant protein of cSZ-JN2 and DNA vaccine carrying cSZ-JN2 could significantly increase the average body weight gains, decrease the mean lesion scores and the oocyst outputs of the immunized chickens and presented anti-coccidial indices of more than 165. All the above results suggested that the cSZ-JN2 was a novel E. acervulina antigen and could be an effective candidate for the development of a new vaccine against E. acervulina infection.
柔嫩艾美耳球虫是引起球虫病的病原体,这是一种严重影响家禽养殖业的疾病。迄今为止,仅报道了少数柔嫩艾美耳球虫的抗原基因。在本研究中,从柔嫩艾美耳球虫裂殖体阶段 cDNA 表达文库中鉴定到一个克隆,命名为 cSZ-JN2,该克隆具有刺激鸡免疫反应的能力。序列分析表明,cSZ-JN2 的开放阅读框(ORF)大小为 153bp,编码一个预测的 50 个氨基酸的 Mr 5.3kDa 蛋白。BLASTN 搜索显示,cSZ-JN2 与已知的柔嫩艾美耳球虫基因或任何其他生物(GenBank)没有显著同源性。在大肠杆菌中表达的重组 cSZ-JN2 抗原被感染柔嫩艾美耳球虫的鸡血清强烈识别。用针对重组 cSZ-JN2 的抗体进行免疫荧光分析表明,该蛋白在裂殖体和配子体发育阶段表达。动物攻毒实验表明,cSZ-JN2 的重组蛋白和携带 cSZ-JN2 的 DNA 疫苗可显著提高免疫鸡的平均体重增加,降低平均病变评分和卵囊产量,并呈现出超过 165 的抗球虫指数。所有这些结果表明,cSZ-JN2 是一种新型柔嫩艾美耳球虫抗原,可作为开发抗柔嫩艾美耳球虫感染的新型疫苗的有效候选物。